Correlation Between Catalyst Pharmaceuticals and ACGCAP

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Catalyst Pharmaceuticals and ACGCAP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Catalyst Pharmaceuticals and ACGCAP into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Catalyst Pharmaceuticals and ACGCAP 195 30 JAN 26, you can compare the effects of market volatilities on Catalyst Pharmaceuticals and ACGCAP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Catalyst Pharmaceuticals with a short position of ACGCAP. Check out your portfolio center. Please also check ongoing floating volatility patterns of Catalyst Pharmaceuticals and ACGCAP.

Diversification Opportunities for Catalyst Pharmaceuticals and ACGCAP

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Catalyst and ACGCAP is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Catalyst Pharmaceuticals and ACGCAP 195 30 JAN 26 in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ACGCAP 195 30 and Catalyst Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Catalyst Pharmaceuticals are associated (or correlated) with ACGCAP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ACGCAP 195 30 has no effect on the direction of Catalyst Pharmaceuticals i.e., Catalyst Pharmaceuticals and ACGCAP go up and down completely randomly.

Pair Corralation between Catalyst Pharmaceuticals and ACGCAP

Given the investment horizon of 90 days Catalyst Pharmaceuticals is expected to generate 1.84 times more return on investment than ACGCAP. However, Catalyst Pharmaceuticals is 1.84 times more volatile than ACGCAP 195 30 JAN 26. It trades about 0.09 of its potential returns per unit of risk. ACGCAP 195 30 JAN 26 is currently generating about -0.01 per unit of risk. If you would invest  1,418  in Catalyst Pharmaceuticals on October 22, 2024 and sell it today you would earn a total of  860.00  from holding Catalyst Pharmaceuticals or generate 60.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy78.95%
ValuesDaily Returns

Catalyst Pharmaceuticals  vs.  ACGCAP 195 30 JAN 26

 Performance 
       Timeline  
Catalyst Pharmaceuticals 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Catalyst Pharmaceuticals are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Catalyst Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in February 2025.
ACGCAP 195 30 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days ACGCAP 195 30 JAN 26 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Bond's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for ACGCAP 195 30 JAN 26 investors.

Catalyst Pharmaceuticals and ACGCAP Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Catalyst Pharmaceuticals and ACGCAP

The main advantage of trading using opposite Catalyst Pharmaceuticals and ACGCAP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Catalyst Pharmaceuticals position performs unexpectedly, ACGCAP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ACGCAP will offset losses from the drop in ACGCAP's long position.
The idea behind Catalyst Pharmaceuticals and ACGCAP 195 30 JAN 26 pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated